340B Drug Pricing & Prior Authorizations

A growing number of complex, expensive medications are entering the market. At the same time, health insurance companies, also called payer, are increasingly relying on utilization management to control healthcare costs by influencing patient care decisions. Common utilization management tools include prior authorizations, step therapy, predeterminations, and preauthorizations.

Electronic Prior Authorization Reform: What’s Next?

The legislation will streamline the prior authorization process for the more than 28 million Medicare Advantage members. Medicare Advantage (MA) plans, sometimes called “Part C” or “MA Plans,” are Medicare-approved plans from private companies offering an alternative to original Medicare for health and medication coverage.

4 Tips for Prior Authorization Success

Prior authorizations (prior auths or PAs) are a cost management tool utilized by insurance companies. PAs increase administrative costs for HCPs and create a healthcare obstacle for patients. HCPs depend on prior authorization approvals and insurance payments to remain in business. Healthcare providers (HCPs) must master a productive prior authorization workflow to improve productivity and revenue.

An Essential Guide to Step Therapy

Health insurance companies increasingly employ cost management strategies as more expensive, specialized drugs enter the market. The use of step therapy is one of these cost-control strategies. The goal of step therapy is for patients to try low-cost medications before moving on to more costly ones.

The Players of Prior Authorization

The prior authorization (prior auth, or PA) process itself can be complicated and requires both communication and a cohesive healthcare team. The healthcare team involved in the PA process consists of a provider or physician, the pharmacy, the payer, and the patient. Each player on this team plays a part in successful and positive patient outcomes.

5 Challenges for Patient Access in 2021

Patient access is at the forefront of healthcare policy and mainstream media as the pandemic and vaccination distribution continues.  In 2020, we saw vast attention on prior authorization, patient access, and related-issues making appearances in healthcare policy. We saw time spent on Step Therapy, Copay Accumulators, Prior Authorizations, and Out-of-Pocket Costs at the local and […]